ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup
2018 · Nature Communications · 218 citations
https://doi.org/10.1038/s41467-018-06498-2
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
5
Papers
1.6K
Citations
2
h-index
2
i10-index
Matthew S. Koletsky is an academic researcher from Rockefeller University. The author has contributed to research in topics: Neuroendocrine Tumor Research Advances & Neuroblastoma Research and Treatments & Glioma Diagnosis and Treatment. The author has an h-index of 2, co-authored 5 publications.
Click to start Chat